Health Catalyst (HCAT)

• Market cap: $277M
• 1 day: -2.95%
• 5 days: -0.75%
• 1 month: -12.80%
• 3 months: -28.44%
• 6 months: -50.87%
• Year to date: -46.19%
• 1 year: -36.50%
• 5 years: -85.19%
• 10 years: -89.92%
• Sector: Healthcare
• Industry: Health Information Services

About: Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

Employees: 1,500

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

18,317% more call options, than puts

Call options by funds: $21M | Put options by funds: $114K

45% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 20

25% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 48

4% more funds holding

Funds holding: 159 [Q3] → 166 (+7) [Q4]

0% more funds holding in top 10

Funds holding in top 10: 2 [Q3] → 2 (+0) [Q4]

0.9% less ownership

Funds ownership: 86.05% [Q3] → 85.14% (-0.9%) [Q4]

11% less capital invested

Capital invested by funds: $423M [Q3] → $376M (-$47.5M) [Q4]

Research analyst outlook

7 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $4 1% upside
• Avg. target: $5.64 43% upside
• High target: $8 103% upside

7 analyst ratings

• positive: 3 43%
• neutral: 4 57%
• negative: 0 0%

Citigroup Daniel Grosslight 40% 1-year accuracy 10 / 25 met price target	65% upside $6.50	Buy Maintained	25 Apr 2025
Keybanc Scott Schoenhaus 54% 1-year accuracy 21 / 39 met price target	27% upside $5	Overweight Maintained	16 Apr 2025
Evercore ISI Group Elizabeth Anderson 42% 1-year accuracy 14 / 33 met price target	1% upside $4	In-Line Downgraded	9 Apr 2025
Stephens & Co. Jeff Garro 70% 1-year accuracy 7 / 10 met price target	27% upside $5	Equal-Weight Maintained	6 Mar 2025
RBC Capital Sean Dodge 36% 1-year accuracy 12 / 33 met price target	52% upside $6	Sector Perform Maintained	27 Feb 2025